Earkart made a landmark impact at the world's largest otolaryngology conference, hosted at Indianapolis, from October 11-13, 2025. This premier event welcomed more than 5,000 ENT specialists, audiologists, researchers, and healthcare leaders representing over 75 countries, all converging to engage with the latest advances in ENT and audiology care.
As part of the official program of 520+ sessions and innovation showcases, Earkart unveiled its next-generation OMNI platform-a remote diagnostic solution transforming access to expert ENT care worldwide. The Earkart booth drew wide attention with live demonstrations of OMNI's real-time, precision diagnostics and remote consultation features. Delegates experienced hands-on engagement with the platform's intuitive interface and connectivity, designed to eliminate traditional barriers and boost efficiency in ear healthcare.
Multiple leading specialists expressed intent to adopt OMNI after witnessing its impact in expanding high-quality, data-driven diagnostics to clinics everywhere. Earkart's booth saw a surge in registration forms, underscoring both the platform's disruptive potential and the trust placed in Earkart's engineering.
Management Commentary: "OMNI empowers specialists to serve patients with precision, wherever they are. This global recognition validates our commitment to advancing intelligent, accessible ENT diagnostics."
Earkart's achievement at this milestone event reflects its mission to drive global transformation in ENT care through innovation and collaboration. OMNI is positioned to power the next wave of digital health adoption in North America, Europe, the Middle East, and emerging healthcare markets.
Shares of Earkart Limited was last trading in BSE at Rs. 208.50 as compared to the previous close of Rs. 219.45. The total number of shares traded during the day was 28000 in over 26 trades.
The stock hit an intraday high of Rs. 218.00 and intraday low of 208.50. The net turnover during the day was Rs. 5861900.00.